{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:25:20Z","timestamp":1792301120067,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bcp.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T20:49:01Z","timestamp":1523652541000},"page":"338-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Nrf2 as a therapeutic target for rheumatic diseases"],"prefix":"10.1016","volume":"152","author":[{"given":"Mar\u00eda Luisa","family":"Ferr\u00e1ndiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Nacher-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.04.010_b0005","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/MCB.15.8.4184","article-title":"Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins","volume":"15","author":"Itoh","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2018.04.010_b0010","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/ars.2010.3211","article-title":"Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases","volume":"13","author":"Villeneuve","year":"2010","journal-title":"Antioxid. Redox Signal"},{"issue":"Part B","key":"10.1016\/j.bcp.2018.04.010_b0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","article-title":"Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease","volume":"88","author":"Tebay","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0020","doi-asserted-by":"crossref","first-page":"20858","DOI":"10.1074\/jbc.M101198200","article-title":"Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation","volume":"276","author":"He","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0025","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/sj.onc.1202237","article-title":"Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes","volume":"17","author":"Venugopal","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2018.04.010_b0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","article-title":"Toward clinical application of the Keap1-Nrf2 pathway","volume":"34","author":"Suzuki","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2018.04.010_b0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","article-title":"Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants","volume":"617","author":"Dinkova-Kostova","year":"2017","journal-title":"Arch Biochem. Biophys."},{"key":"10.1016\/j.bcp.2018.04.010_b0040","doi-asserted-by":"crossref","first-page":"16817","DOI":"10.1074\/jbc.R117.800169","article-title":"Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress","volume":"292","author":"Suzuki","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0045","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/MCB.01639-08","article-title":"Acetylation of Nrf2 by p300\/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response","volume":"29","author":"Sun","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2018.04.010_b0050","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1074\/jbc.M110.208173","article-title":"Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization","volume":"286","author":"Kawai","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gene.2016.04.040","article-title":"BACH1, the master regulator gene: a novel candidate target for cancer therapy","volume":"588","author":"Davudian","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2018.04.010_b0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ni.3772","article-title":"Limiting inflammation-the negative regulation of NF-[kappa]B and the NLRP3 inflammasome","volume":"18","author":"Afonina","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2018.04.010_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2018.04.010_b0070","first-page":"12","article-title":"Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases","volume":"34","author":"Zhong","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2018.04.010_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ars.2015.6615","article-title":"Nuclear factor E2-related factor-2 negatively regulates NLRP3 inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming","volume":"26","author":"Liu","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bcp.2018.04.010_b0080","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1074\/jbc.M114.563114","article-title":"Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0085","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2018.04.010_b0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2018.04.010_b0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-KB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bcp.2018.04.010_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2009.07.025","article-title":"KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta","volume":"36","author":"Lee","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2018.04.010_b0105","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1038\/srep03242","article-title":"MafK positively regulates NF-kappaB activity by enhancing CBP-mediated p65 acetylation","volume":"3","author":"Hwang","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.04.010_b0110","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/ars.2016.6754","article-title":"15-Deoxy-(delta)12,14-prostaglandin J2 exerts pro-resolving effects through Nrf2-induced expression of CD36 and heme oxygenase-1","volume":"27","author":"Kim","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.bcp.2018.04.010_b0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.2001.00939.x","article-title":"Nrf2-deficient female mice develop lupus-like autoimmune nephritis","volume":"60","author":"Yoh","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2018.04.010_b0120","doi-asserted-by":"crossref","first-page":"e00063","DOI":"10.1128\/MCB.00063-17","article-title":"Systemic activation of NRF2 alleviates lethal autoimmune inflammation in scurfy mice","volume":"37","author":"Suzuki","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2018.04.010_b0125","doi-asserted-by":"crossref","first-page":"22281","DOI":"10.1074\/jbc.M113.483420","article-title":"Nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) modulates dendritic cell immune function through regulation of p38 MAPK-cAMP-responsive element binding protein\/activating transcription factor 1 signaling","volume":"288","author":"Al-Huseini","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2015.02.004","article-title":"Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability","volume":"83","author":"Sha","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2017.11.005","article-title":"Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation","volume":"147","author":"Zagorski","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.04.010_b0140","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.1101712","article-title":"Th2 skewing by activation of Nrf2 in CD4(+) T cells","volume":"188","author":"Rockwell","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2018.04.010_b0145","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.4049\/jimmunol.1700812","article-title":"KEAP1 editing using CRISPR\/Cas9 for therapeutic NRF2 activation in primary human T lymphocytes","volume":"200","author":"Noel","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2018.04.010_b0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2353\/ajpath.2008.070963","article-title":"Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells","volume":"173","author":"George","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2018.04.010_b0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2015.00571","article-title":"The interplay between monocytes\/macrophages and CD4+ T cell subsets in rheumatoid arthritis","volume":"6","author":"Roberts","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2018.04.010_b0160","doi-asserted-by":"crossref","first-page":"e0152925","DOI":"10.1371\/journal.pone.0152925","article-title":"Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis","volume":"11","author":"Mateen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.04.010_b0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/ard.2010.132720","article-title":"Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice","volume":"70","author":"Wruck","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2018.04.010_b0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/RHU.0b013e3181ba3926","article-title":"Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients","volume":"15","author":"van Wietmarschen","year":"2009","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2018.04.010_b0175","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/ars.2010.3835","article-title":"Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease","volume":"15","author":"Maicas","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2018.04.010_b0180","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.21356","article-title":"Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis","volume":"52","author":"Devesa","year":"2005","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.bcp.2018.04.010_b0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.redox.2016.08.011","article-title":"S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway","volume":"10","author":"Wu","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2018.04.010_b0190","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/MCB.01591-09","article-title":"Genetic analysis of cytoprotective functions supported by graded expression of Keap1","volume":"30","author":"Taguchi","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2018.04.010_b0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/art.25017","article-title":"Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate","volume":"62","author":"Kong","year":"2010","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.bcp.2018.04.010_b0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2016.03.008","article-title":"Sulforaphane regulates phenotypic and functional switching of both induced and spontaneously differentiating human monocytes","volume":"35","author":"Pal","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2018.04.010_b0205","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/ar4059","article-title":"Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytes","volume":"14","author":"Fragoulis","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2018.04.010_b0210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/eji.201646665","article-title":"Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression","volume":"47","author":"Garstkiewicz","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2018.04.010_b0215","doi-asserted-by":"crossref","first-page":"rs10","DOI":"10.1126\/scisignal.aaf7694","article-title":"Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells","volume":"9","author":"Blewett","year":"2016","journal-title":"Sci. Signal"},{"key":"10.1016\/j.bcp.2018.04.010_b0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-015-1422-3","article-title":"Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS","volume":"130","author":"Parodi","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bcp.2018.04.010_b0225","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2982","article-title":"Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise","volume":"12","author":"Ahmed","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"Part A","key":"10.1016\/j.bcp.2018.04.010_b0230","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.phrs.2016.09.031","article-title":"Calycosin suppresses expression of pro-inflammatory cytokines via the activation of p62\/Nrf2-linked heme oxygenase 1 in rheumatoid arthritis synovial fibroblasts","volume":"113","author":"Su","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.04.010_b0235","doi-asserted-by":"crossref","first-page":"34074","DOI":"10.1074\/jbc.M105383200","article-title":"Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2\/small Maf by antirheumatic gold(I) compounds","volume":"276","author":"Kataoka","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0240","doi-asserted-by":"crossref","first-page":"593","DOI":"10.15252\/emmm.201404702","article-title":"Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2","volume":"7","author":"Bretscher","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI9652","article-title":"15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats","volume":"106","author":"Kawahito","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2018.04.010_b0250","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1021\/mp100199m","article-title":"Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid","volume":"7","author":"Wang","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2018.04.010_b0255","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clnu.2017.02.021","article-title":"Docosahexaenoic acid in the treatment of rheumatoid arthritis: a double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil","volume":"37","author":"Dawczynski","year":"2018","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bcp.2018.04.010_b0260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","article-title":"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations","volume":"52","author":"Frostegard","year":"2005","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.bcp.2018.04.010_b0265","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/0961203310367917","article-title":"The NRF2 gene variant, -653G\/A, is associated with nephritis in childhood-onset systemic lupus erythematosus","volume":"19","author":"Cordova","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bcp.2018.04.010_b0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2013.343","article-title":"Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-kappaB-mediated inflammatory response","volume":"85","author":"Jiang","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2018.04.010_b0275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/physiolgenomics.00209.2003","article-title":"Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice","volume":"18","author":"Li","year":"2004","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bcp.2018.04.010_b0280","doi-asserted-by":"crossref","first-page":"38619","DOI":"10.1038\/srep38619","article-title":"Nuclear factor erythroid 2-related factor 2 deficiency exacerbates lupus nephritis in B6\/lpr mice by regulating Th17 Cell function","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.04.010_b0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13075-016-1039-5","article-title":"Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis","volume":"18","author":"Ebihara","year":"2016","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.bcp.2018.04.010_b0290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bjd.14698","article-title":"Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters","volume":"176","author":"Saracino","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bcp.2018.04.010_b0295","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.freeradbiomed.2011.05.016","article-title":"Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation","volume":"51","author":"Tsai","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.12.012","article-title":"Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritis","volume":"108","author":"Portal-Nu\u00f1ez","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.04.010_b0305","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1063-4584(03)00150-X","article-title":"The role of reactive oxygen species in homeostasis and degradation of cartilage","volume":"11","author":"Henrotin","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bcp.2018.04.010_b0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bone.2006.08.016","article-title":"Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis","volume":"40","author":"Hinoi","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2018.04.010_b0315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.freeradbiomed.2018.01.013","article-title":"Nrf2\/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1\/2\/ELK1-P70S6K-P90RSK signaling axis","volume":"116","author":"Khan","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0320","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jcb.25659","article-title":"Elucidating the role of protandim and 6-gingerol in protection against osteoarthritis","volume":"118","author":"Abusarah","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2018.04.010_b0325","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13075-015-0774-3","article-title":"Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis","volume":"17","author":"Cai","year":"2015","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.bcp.2018.04.010_b0330","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20120491","article-title":"Haem oxygenase-1 induction reverses the actions of interleukin-1beta on hypoxia-inducible transcription factors and human chondrocyte metabolism in hypoxia","volume":"125","author":"Clerigues","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bcp.2018.04.010_b0335","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/rheumatology\/kep463","article-title":"Heme oxygenase-1 down-regulates high mobility group box 1 and matrix metalloproteinases in osteoarthritic synoviocytes","volume":"49","author":"Garcia-Arnandis","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcp.2018.04.010_b0340","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bcp.2011.11.024","article-title":"Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1beta in osteoarthritic osteoblasts","volume":"83","author":"Clerigues","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.04.010_b0345","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1039\/C7FO00822H","article-title":"Piceatannol inhibits the IL-1beta-induced inflammatory response in human osteoarthritic chondrocytes and ameliorates osteoarthritis in mice by activating Nrf2","volume":"8","author":"Tang","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2018.04.010_b0350","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.freeradbiomed.2017.02.041","article-title":"Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS\/ERK\/Nrf2 signaling pathways in human Osteoarthritis chondrocytes","volume":"106","author":"Khan","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2017.08.007","article-title":"Epigenetics in osteoarthritis: potential of HDAC inhibitors as therapeutics","volume":"128","author":"Khan","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.04.010_b0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/BOR.0000000000000456","article-title":"Targeting aging for disease modification in osteoarthritis","volume":"30","author":"Collins","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2018.04.010_b0365","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/art.38133","article-title":"Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo","volume":"65","author":"Davidson","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2018.04.010_b0370","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of osteoporosis: a mini-review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology"},{"key":"10.1016\/j.bcp.2018.04.010_b0375","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00223-014-9900-5","article-title":"Nrf2 deficiency impairs fracture healing in mice","volume":"95","author":"Lippross","year":"2014","journal-title":"Calcified Tissue Int."},{"key":"10.1016\/j.bcp.2018.04.010_b0380","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1074\/jbc.M113.478545","article-title":"The Keap1\/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling","volume":"288","author":"Kanzaki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.freeradbiomed.2013.08.005","article-title":"Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation","volume":"65C","author":"Hyeon","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0390","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.freeradbiomed.2012.10.536","article-title":"Loss of Nrf2 accelerates Ionizing radiation-induced bone loss by upregulating RANKL","volume":"53","author":"Rana","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0395","doi-asserted-by":"crossref","first-page":"e0171161","DOI":"10.1371\/journal.pone.0171161","article-title":"Nrf2 regulates mass accrual and the antioxidant endogenous response in bone differently depending on the sex and age","volume":"12","author":"Pellegrini","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.04.010_b0400","doi-asserted-by":"crossref","first-page":"18015","DOI":"10.1074\/jbc.M600603200","article-title":"Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation","volume":"281","author":"Hinoi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.04.010_b0405","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bone.2014.01.025","article-title":"Nrf2 is a novel regulator of bone acquisition","volume":"63","author":"Park","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2018.04.010_b0410","doi-asserted-by":"crossref","first-page":"14033","DOI":"10.1038\/boneres.2014.33","article-title":"Nrf2 is required for normal postnatal bone acquisition in mice","volume":"2","author":"Kim","year":"2014","journal-title":"Bone Res."},{"key":"10.1016\/j.bcp.2018.04.010_b0415","doi-asserted-by":"crossref","first-page":"726590","DOI":"10.1155\/2014\/726590","article-title":"Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis","volume":"2014","author":"Iba\u00f1ez","year":"2014","journal-title":"Oxid. Med. Cell Longevity"},{"key":"10.1016\/j.bcp.2018.04.010_b0420","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ijbiomac.2017.10.080","article-title":"MiR-455-3p activates Nrf2\/ARE signaling via HDAC2 and protects osteoblasts from oxidative stress","volume":"107","author":"Zhang","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2018.04.010_b0425","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jcmm.13367","article-title":"Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation","volume":"22","author":"Yamaguchi","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0430","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/0022034515577814","article-title":"Nrf2 activation attenuates both orthodontic tooth movement and relapse","volume":"94","author":"Kanzaki","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bcp.2018.04.010_b0435","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00109-017-1553-1","article-title":"Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-kappaB and MAPK signalling","volume":"95","author":"Thummuri","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bcp.2018.04.010_b0440","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.intimp.2009.03.001","article-title":"Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos","volume":"9","author":"Ha","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2018.04.010_b0445","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.freeradbiomed.2014.09.006","article-title":"Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis","volume":"77","author":"Kanzaki","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2018.04.010_b0450","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bbrc.2017.06.184","article-title":"Mangiferin protects osteoblast against oxidative damage by modulation of ERK5\/Nrf2 signaling","volume":"491","author":"Xia","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.04.010_b0455","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2015.03.049","article-title":"Indole-3-carbinol as inhibitors of glucocorticoid-induced apoptosis in osteoblastic cells through blocking ROS-mediated Nrf2 pathway","volume":"460","author":"Lin","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.04.010_b0460","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopha.2017.11.136","article-title":"Alpinumisoflavone protects against glucocorticoid-induced osteoporosis through suppressing the apoptosis of osteoblastic and osteocytic cells","volume":"96","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2018.04.010_b0465","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.18632\/oncotarget.13732","article-title":"Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2018.04.010_b0470","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fj.201600826R","article-title":"RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice","volume":"31","author":"Kanzaki","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2018.04.010_b0475","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.febslet.2012.05.016","article-title":"The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops","volume":"586","author":"Papp","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2018.04.010_b0480","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fphar.2014.00224","article-title":"Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacology","volume":"5","author":"Wani","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2018.04.010_b0485","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.12688\/f1000research.12111.1","article-title":"Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate","volume":"6","author":"Satoh","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.bcp.2018.04.010_b0490","doi-asserted-by":"crossref","first-page":"e0135257","DOI":"10.1371\/journal.pone.0135257","article-title":"Cancer cell growth is differentially affected by constitutive activation of NRF2 by KEAP1 deletion and pharmacological activation of NRF2 by the synthetic triterpenoid, RTA 405","volume":"10","author":"Probst","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.04.010_b0495","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1523\/JNEUROSCI.1304-15.2015","article-title":"Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia","volume":"35","author":"Tu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2018.04.010_b0500","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1021\/acs.jmedchem.6b00586","article-title":"Discovery and development of Kelch-like ECH-associated protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) protein-protein interaction inhibitors: achievements, challenges, and future directions","volume":"59","author":"Jiang","year":"2016","journal-title":"J. Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218301539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218301539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T20:56:11Z","timestamp":1720212971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218301539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":100,"alternative-id":["S0006295218301539"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.04.010","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 as a therapeutic target for rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}